At the forefront of discovery and development.
We’re experts in the design and characterization of small-molecule drugs.
We are known for our deep, embedded knowledge in key areas of the drug discovery process. ARIAD utilizes a highly sophisticated and effective combination of computational and structural approaches to drug design based on a solid understanding of how our drugs bind to their targets.
Our core lead-discovery approaches center on virtual and fragment-based screening, and we have developed novel technology platforms such as P-SMART chemistry and ARGENT cell-signaling regulation that we integrate into our lead-generation process.
